Sprayed copper peroxide nanodots for accelerating wound healing in a multidrug-resistant bacteria infected diabetic

Ran Zhang1, Guhua Jiang1, Qianqian Gao2

  • 1Department of Preventive Medicine and Public Health Laboratory Science, School of Medicine, Jiangsu University, Zhenjiang 212013, China. shenhj@ujs.edu.cn.

Nanoscale
|September 15, 2021
PubMed

Insights

Copper peroxide (CuO2) nanodots effectively treat diabetic ulcers by killing bacteria and promoting blood vessel growth. These sprayable nanodots offer a promising solution for infected wounds with minimal toxicity.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Wound Healing

Background:

  • Diabetic ulcers often fail to heal due to vascular dysfunction and bacterial infections.
  • Current treatments like growth factors and antibiotics have limitations such as short half-lives, high costs, and antibiotic resistance.
  • Novel agents with combined angiogenic and antibacterial properties are needed for effective diabetic ulcer treatment.

Purpose of the Study:

  • To investigate the potential of copper peroxide (CuO2) nanodots as a therapeutic agent for infected diabetic ulcers.
  • To evaluate the antibacterial and angiogenic activities of CuO2 nanodots.
  • To assess the efficacy and safety of sprayable CuO2 nanodots in a preclinical setting.

Main Methods:

  • CuO2 nanodots were synthesized and characterized.
  • In vitro antibacterial activity was tested against various bacterial strains, including MRSA.
  • In vitro angiogenic potential was assessed by measuring HIF-1α and VEGF expression in HUVECs, and evaluating cell migration and tube formation.
  • In vivo efficacy was evaluated in a mouse model of infected diabetic ulcers, assessing bacterial load, inflammation, angiogenesis, and wound healing.
  • Systemic toxicity was also evaluated.

Main Results:

  • CuO2 nanodots demonstrated potent bactericidal effects against E. coli, S. aureus, P. aeruginosa, and MRSA in vitro.
  • CuO2 nanodots significantly induced HIF-1α and VEGF expression in HUVECs, promoting angiogenesis.
  • In vivo studies showed that sprayed CuO2 nanodots effectively reduced MRSA burden, decreased inflammation, enhanced angiogenesis, and accelerated wound healing.
  • The treatment exhibited negligible systemic toxicity.

Conclusions:

  • CuO2 nanodots possess dual antibacterial and angiogenic properties, making them suitable for treating infected diabetic ulcers.
  • Sprayable CuO2 nanodots offer a convenient and effective therapeutic strategy for promoting diabetic ulcer healing.
  • This study provides strong evidence for the clinical potential of CuO2 nanodots in managing complex wound infections.